For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

mAbs synthesized in the laboratory mimic natural antibodies produced by the body and are designed to target and neutralize pathogenic proteins or antigens selectively. A specific class of mAb, capable ...

In this webinar, Daryl Cole will share insights into the high-throughput screening and analysis of antibody binding and functional characterization.

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering.